课题基金 / 基金详情

FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE

FLANKING BASE SEQUENCE ON MUTAGENICITY OF 8 OXOGUANINE
8 氧鸟嘌呤致突变性的侧翼碱基序列
批准号:
6362773
负责人:
Paul Thomas Henderson
金额:
$4.02万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-03-01 至

项目摘要

项目成果

Paul Thomas Henderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION The goal of this project is to determine how DNA repair and replication pathways respond to the presence of the DNA adduct 8-oxoguanine (8- oxoG) in a systematically varied sequence context. The mutation frequency of damaged guanine in hotspots is likely to be governed by their flanking context.. To address this possibility, a series of sixteen oligonucleotides containing 8-oxoG flanked by all possible 5'-and 3'- based variations will be synthesized. The oligonucleotides will be placed into viral vectors for in vivo determination of mutational frequency after transfection into E. coli. Cells lacking expression of the two known 8- oxoG base excision repair enzymes, MutM and MutY, will address the impact of sequence effects on polymerase misincorporation; while cells expressing either one or both glycolyases will determine which repair system is most affected by sequence context, as determined by their relative mutation frequencies. The oligonucleotides will also be hybridized to their complements to form short duplexes for in vitro studies. The duplexes will be analyzed by thermal UV spectroscopy to determine the free energy, enthalpy and temperature of melting compared to non-lesion containing controls. The 8-oxoG containing duplexes will also be radiolabeled and digested with MutM or MutY at various concentrations to determine the rate of repair and the dissociation constant of the enzyme-substrate complex. These physiochemical data will be correlated to the mutation frequency found for each sequence context in an effort to model selective mutation or repair of oxidative DNA lesions (hot- and coldspots-respectively).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ninja Theranostics for overcoming the drug delivery barriers to pediatric brain tumor
  • 批准号:
    9681305
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2018
  • 负责人:
    Paul Thomas Henderson
  • 依托单位:
Phase 0 carboplatin microdosing diagnostics trial
DEVELOP ASSAY TO QUANT PLAT-DNA ADDUCTS & PREDICT RESPONSE TO CHEMOTHERA
OXIDIZED DNA BASES AS BIOMARKERS OF TUMOR PROGRESSION
海外基金